Clinical trial
Spacer Comparison In Adult Asthmatics
NCT00369993 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00369993 |
|---|---|
| Title | Spacer Comparison In Adult Asthmatics |
| Official title | A Randomised, Open Label, Five-way Crossover Study to Assess the Systemic Exposure of Fluticasone Propionate and Salmeterol From SERETIDE/ADVAIR 250HFA MDI Alone and With AeroChamber-Max Spacer and VOLUMATIC Both in Their Washed and Unwashed States in Adult Subjects With Mild or Intermittent Asthma |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | fluticasone propionate/salmeterol |
| Enrollment | 20 |
| Start date | Mar 1, 2005 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Aug 30, 2006 |
| Last update posted | Oct 17, 2016 |
| Countries | New Zealand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: